Activation of neuroimmune pathways increases therapeutic effects of radiotherapy on poorly differentiated breast carcinoma.
Recent studies document the importance of neuronal dysfunction in cancer development and metastasis. We reported previously that both depletion of neuropeptides in capsaicin-sensitive sensory nerve endings and vagotomy increases metastasis of triple negative breast carcinoma. Of the sensory neuropeptides, Substance P (SP) is distributed widely for regulation of immune functions. We therefore examined the affects of continuous exposure to low doses of SP on brain metastatic cells of the mouse breast carcinoma (4TBM) in the presence of radiotherapy (RT) thought to increase antigenicity of cancer cells. 4TBM cells have a cancer stem cell phenotype and induce extensive visceral metastasis after orthotopic inoculation into the mammary pad. Results demonstrated that SP treatment decreases the number of tumor-infiltrating myeloid-derived suppressor cells as well as the TNF-α response to LPS challenge. SP also increased CD4+Cd25(bright) cells in draining lymph nodes of tumor-bearing animals and IFN-γ secretion from leukocyte culture prepared from lymph nodes and spleens of tumor-bearing animals. SP also prevented tumor-induced degeneration of sensory nerve endings and altered release of angiogenic factors from cancer-associated fibroblasts (CAF) and tumor explants. In accordance with these observed immunological effects, combination treatment of continuous SP with a single dose of RT induced complete tumor regression and significantly reduced or prevented metastasis in 50% of the animals while suppressing primary tumor growth and metastasis in the remaining mice. These original findings demonstrate that SP through neuroimmune modulation can prevent formation of immune suppression in the tumor microenvironment, enhance cytotoxic immunity in the presence of RT and prevent metastatic growth.
Department of Medical Pharmacology, Akdeniz University, School of Medicine, Antalya, Turkey. Electronic address: nerin@akdeniz.edu.tr.
Nuray
N
Erin
Radiation Oncology, Akdeniz University, School of Medicine, Antalya, Turkey.
Aylin F
AF
Korcum
Histology and Embryology, Akdeniz University, School of Medicine, Antalya, Turkey.
Gamze
G
Tanrıöver
Department of Medical Pharmacology, Akdeniz University, School of Medicine, Antalya, Turkey.
Şule
Ş
Kale
Histology and Embryology, Akdeniz University, School of Medicine, Antalya, Turkey.
Necdet
N
Demir
Medical Microbiology and Immunology, Akdeniz University, School of Medicine, Antalya, Turkey.
Sadi
S
Köksoy
D000818:Animals; D001932:Brain Neoplasms / Q000188:drug therapy / Q000378:metabolism / Q000532:radiotherapy* / Q000556:secondary; D001943:Breast Neoplasms / Q000378:metabolism / Q000473:pathology*; D045744:Cell Line, Tumor; D003131:Combined Modality Therapy; D004195:Disease Models, Animal; D000077143:Docetaxel; D005260:Female; D051379:Mice; D008807:Mice, Inbred BALB C; D013373:Substance P / Q000494:pharmacology / Q000627:therapeutic use*; D043823:Taxoids / Q000494:pharmacology / Q000627:therapeutic use; D016896:Treatment Outcome
D043823:Taxoids; D000077143:Docetaxel; D013373:Substance P
Breast cancer; CD8; Capsaicin; Metastasis; Radiotherapy; Sensory nerve endings; Substance P